Fonte: Investigative Ophthalmology and Visual Science. Unidade: FMRP
Assuntos: NEOVASCULARIZAÇÃO PATOLÓGICA (TRATAMENTO), DEGENERAÇÃO MACULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Rogério A. et al. Intravitreal bevacizumab for choroidal neovascularization caused by AMD(IBeNA study): results of a phase 1 dose-escalation study. Investigative Ophthalmology and Visual Science, v. 47, n. 10, p. 4569-4578, 2006Tradução . . Acesso em: 28 nov. 2025.APA
Costa, R. A., Jorge, R., Calucci, D., Cardillo, J. A., Melo Júnior, L. A., & Scott, I. U. (2006). Intravitreal bevacizumab for choroidal neovascularization caused by AMD(IBeNA study): results of a phase 1 dose-escalation study. Investigative Ophthalmology and Visual Science, 47( 10), 4569-4578.NLM
Costa RA, Jorge R, Calucci D, Cardillo JA, Melo Júnior LA, Scott IU. Intravitreal bevacizumab for choroidal neovascularization caused by AMD(IBeNA study): results of a phase 1 dose-escalation study. Investigative Ophthalmology and Visual Science. 2006 ; 47( 10): 4569-4578.[citado 2025 nov. 28 ]Vancouver
Costa RA, Jorge R, Calucci D, Cardillo JA, Melo Júnior LA, Scott IU. Intravitreal bevacizumab for choroidal neovascularization caused by AMD(IBeNA study): results of a phase 1 dose-escalation study. Investigative Ophthalmology and Visual Science. 2006 ; 47( 10): 4569-4578.[citado 2025 nov. 28 ]
